This page has been accessed
Symptoms most commonly begin between the ages of 15 and
35, but may appear a little earlier or much later in life. Progression
may be fast or slow, and life expectancy ranges from 10 to 30
years after the disease begins.
How is Joseph disease inherited?
Joseph disease is an autosomal dominant disorder. This means that
each child of an affected parent has a 50 percent chance of inheriting
the defective gene. Joseph disease does not skip generations,
but people at risk who escape the disease will not pass it on
to their children or future generations. People at risk must decide
whether to have children without knowing for sure whether they
might pass the gene on. As with any inherited disorder, Joseph
disease is not contagionus and cannot be "caught" by
people who are not at risk.
How is the disease diagnosed?
Joseph disease is diagnosed by identifying the typical
symptoms in a family in which the disease occurs. Characteristic
features include progressive difficulty in walking an speech beginning
in the late teen years or in the 20's through the 50's. The gait
is abnormal due to spsticity and speec is slurred because of spastic
weakness in the throat muscles. The Joseph disease patient may
be unable to look upward or inward, and the eyes may oscillate
from side to side.
Late-onset Joseph disease, the type that begins when a patient
is 70 or older, is characterized by an uncoodinated gait that
may cause the patient to stumble or fall, the slurring speech,
and the loss of muscle in the arms and legs.
Neurologists have classified Joseph disease into three types,
depending on age at onset and characteristic symptoms. But it
is uncertian whether the three types are subtypes of the same
disease or three sepraate diseases. Because the three types have
at times borne different names, the plural term Joseph diseases
has been used. (I have heard the term 'Machado-Joseph Disease'
used. [tj])
What research is being done?
The National Institute of Neurological and Comunicative
Disorders and Stroke (NINCDS) conducts and supports research on
all disorders of the nervous system, including Joseph disease.
Much of this research is relevant to different aspects of Joseph
disease, and may lead to treatment, a cure, and eventually prevention.
NINVDS is studying normal and defective genes to understand
how inherited characteristics are transmitted. With such knowledge
and improved genetic engineering techniques, intervention and
a cure for inherited disorders like Joseph disease might be possible.
A number of other neurological disorders share symptoms
with Joseph disease, and research conducted on these disorders
should benefit Joseph disease patients. NINCDS scientists are
studying the degeneration of the brain's cerebellum that occurs
in the ataxias. This type of degeneration produces the kind of
spasticity and tremor seen in Joseph disease. NINCDS research
on motor neuron diseases, including amyotorphic lateral sclerosis
and spastic paraplegia, focuses on the deterioration of certian
nerve cells in the spinal cord that also degenerate in Joseph
disease.
Much NINCDS-supported research on Parkinson's disease
is relevant to Joseph disease. The brain's substantia nigra area
is under study because it deteriorates in both disorders. The
development of drugs that will increase dopamine-a brain chemical
missing in Parkinson's disease-may produce an effective therapy
for symptoms of Joseph disease. Investigators using a special
imaging technique called positron emission tomography (PET) have
already produced the first pictures of dopamine at work in the
living brain. Further studies with PET may increase our understanding
of dopamine's possible connection to Joseph disease.
Some scientists are studying the role of enzymes in olivonpontocerebellar
atrophy, a rare inherited neurological disorder similar to Joseph
disease. These studies may uncover an enzyme defect that could
also be responsible for Joseph disease.
Some patients with Joseph disease have high blood glucose
levels and abnormal glucose tolerace test results. Research has
also shown that some patients have reduced levels of homovanillic
acid(a nervous system chemical) in their spinal fluid. These abnormalities
are of special interest to scientists studying Joseph disease.
How can I help research?
The National Institute of Neurological and Communicative
Disords and Stroke and the National Institute of Mental Health
support two national human brain specimen banks, one at the Wadsworth
Vetrans Administration Hospital in Los Angeles and the other at
McLean Hospital near Boston. These banks supply investigators
around the world with tissue from patients with neurological and
psychiatric diseases. Both banks need brain tissue from Joseph
disease patients to enable scientists to study this disorder more
intensely. Prospective donors whould write to:
Dr. Wallace W. Tourtellotte, Director
Human Neurospecimen Bank
VA Wadsworth Medical Center
Building 212, Room 31
Los Angeles, Ca 90073
Telephone: (213) 824-4307 (Call Collect.)
Dr. Edward D. Bird, Director Brain Tissue Bank, Mailman Research
Center McLean Hospital 115 Mill Street Belmont, Massachusetts
02178 Telephone (617) 885-2400 (Call collect 24 hours a day.)
Where can I get help?
The International Joseph Diseases Foundation is a
voluntary, nonprofit organization of concerned people including
patients, their families and friends, and health- care professionals.
The foundation provides information about the disease, supports
and conducts clinical research, and helps patients find medical,
social, and genetic counseling services.
Contact:
International Joseph Diseases Foundation, Inc.
P.O. Box 2550
Livermore, California 94550
NINCDS information
For additional information concerning Joseph disease
research supported by the National Institute of Neurological and
Communicative Disorders and Stroke, contact:
Office of Scientific and Health Reports
National Institute of Neurological and Communicative
Disorders and Stroke
Building 31, Room 8A-06
National Institutes of Health
Bethesda, Maryland 20892
(301) 496-5751
** A reproduction of NIH Publication No. 85-2716 August 1985. Prepared by Office of Scientific and Health Reports National Institute of Neurological and Communicative Disorders and Stroke. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health.